Find your next paid study

Medicenna Therapeutics, Inc.NCT05086692

Actual pay is set by the research site.

CancerNeoplamsRefractory+5 more

xDRIVE Functional Precision Medicine + Artificial Intelligence Individualized Treatments for Florida-based Cancer Patients With Relapsed/ Refractory Cancers

Through this study funded by the Florida Cancer Innovation Fund, First Ascent will demonstrate state-wide feasibility of providing xDRIVE Functional Precision …

First Ascent Biomedical Inc.NCT07167381

~$10 – $1,050

Actual pay is set by the research site.

Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients

Participants recruited for this study will be breast cancer or gynecological cancer patients who agree to participate in an exercise study examining the effect…

Breast CancerGynecologic CancersMitochondrial Function

University of South CarolinaNCT06672497

Actual pay is set by the research site.

Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study HSC transplantation and cellular…

Autologous Stem Cell TransplantationAllogeneic Stem Cell TransplantationSolid Tumors+4 more

Center for International Blood and Marrow Transplant ResearchNCT01166009

~$10 – $1,125

Actual pay is set by the research site.

A Preliminary Elucidation of the Role of Dietary Fiber in Mitigating Sarcopenia Risk in Head and Neck Cancer

Emerging data suggest consumption of dietary fiber before and during cancer treatment may improve prognosis for patients with head and neck cancer, in part via…

Head and Neck Cancers

University of OklahomaNCT07622914

Actual pay is set by the research site.

Pelvic RadiotherapyVaginal StenosisPelvic Cancer+3 more

Improving Engagement With Vaginal Dilator Therapy After Pelvic Radiation: A Pilot Randomized Controlled Trial

This study is testing a new program to help women who have had pelvic radiation therapy to use vaginal dilators more regularly. Vaginal dilators are important …

Duke UniversityNCT07216456

Actual pay is set by the research site.

Hematologic MalignanciesLymphomaMultiple Myeloma+2 more

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

The purpose of this study is to evaluate whether a novel decision support tool called PRIME (Preference Reporting to Improve Management and Experience), which …

UNC Lineberger Comprehensive Cancer CenterNCT06296368

Actual pay is set by the research site.

Phase 1

Phase 1a/1b Study of CT-95 in Advanced Cancers Associated With Mesothelin Expression

This is a Phase 1a/1b, first-in-human (FIH), open-label, multi-center dose escalation and expansion study of the safety, pharmacokinetics (PK), pharmacodynamic…

Mesothelin-Expressing TumorsEpithelial Ovarian CancerMalignant Pleural Mesothelioma, Advanced+8 more

Context Therapeutics Inc.NCT06756035

Actual pay is set by the research site.

HPVHPV Associated CancersHPV Cancers+2 more

Advancing Cervical Cancer Screening Through Emergency Department-based Self-Sampling

This project will compare the uptake of cervical cancer screening through ED HPV sampling among patients presenting to the ED.

University of RochesterNCT07345897

Actual pay is set by the research site.

Phase 1

SI-B036-ST-101: A Multicenter, Open-Label, Phase 1/1b, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SI-B036 in Adult Patients With Advanced/Metastatic Solid Tumors That Are Refractory to Standard Therapies

The objective of the study is to evaluate the safety and tolerability of SI-B036 in participants with solid tumors who have received at least one prior line of…

Locally Advanced /Metastatic Solid TumorsLocally Advanced / Metastatic Solid TumorsMetastatic Solid Cancers+5 more

SystImmune Inc.NCT07857616

Actual pay is set by the research site.

Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Study

Purpose Pancreatic cancer is the fourth leading cancer-related mortality disease in the United States, with a five-year survival rate of 11%, and only 10 15% o…

Pancreatic CancersPancreatic Diseases

Clear Cell Renal Cell CarcinomaRenal Cell CarcinomaRCC+6 more

~$10 – $1,125

Actual pay is set by the research site.

Do Hyun ParkNCT07030348

Phase 1

An Open-Label, First-in-Human, Phase 1/2 Dose Escalation and Expansion Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

The NEO-811-101 study is an open-label, first-in-human, Phase 1/2 dose escalation and expansion study testing NEO-811, an ARNT molecular glue degrader, in subj…